Pharmaceutical companies exploited a regulatory loophole that allowed for a decades-long boom in licit opioid production fueled by Tasmanian-grown poppies. Here's what the island can tell us about the next wave of the crisis.
Despite some advances in how the FDA treats donations of blood from gay men, there's a long way to go to equality.
Internal company documents that have emerged in a New Jersey trial make clear that marketing for Tylenol did not convey doctors’ concerns about its risks.
Federal regulators announce that they will examine the regulation of non-prescription drugs such as acetaminophen, the active ingredient in Tylenol.